533 related articles for article (PubMed ID: 32414157)
1. Erythropoietin Ameliorates Ischemia/Reperfusion-Induced Acute Kidney Injury via Inflammasome Suppression in Mice.
Kwak J; Kim JH; Jang HN; Jung MH; Cho HS; Chang SH; Kim HJ
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32414157
[TBL] [Abstract][Full Text] [Related]
2. Potent Therapy and Transcriptional Profile of Combined Erythropoietin-Derived Peptide Cyclic Helix B Surface Peptide and Caspase-3 siRNA against Kidney Ischemia/Reperfusion Injury in Mice.
Wu Y; Chen W; Zhang Y; Liu A; Yang C; Wang H; Zhu T; Fan Y; Yang B
J Pharmacol Exp Ther; 2020 Oct; 375(1):92-103. PubMed ID: 32759272
[TBL] [Abstract][Full Text] [Related]
3. Hydroxychloroquine attenuates renal ischemia/reperfusion injury by inhibiting cathepsin mediated NLRP3 inflammasome activation.
Tang TT; Lv LL; Pan MM; Wen Y; Wang B; Li ZL; Wu M; Wang FM; Crowley SD; Liu BC
Cell Death Dis; 2018 Mar; 9(3):351. PubMed ID: 29500339
[TBL] [Abstract][Full Text] [Related]
4. Human Endothelial Progenitor Cells Protect the Kidney against Ischemia-Reperfusion Injury via the NLRP3 Inflammasome in Mice.
Jang HN; Kim JH; Jung MH; Tak T; Jung JH; Lee S; Jung S; Chang SH; Kim HJ
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163466
[TBL] [Abstract][Full Text] [Related]
5. Caspase-11 promotes NLRP3 inflammasome activation via the cleavage of pannexin1 in acute kidney disease.
Yin F; Zheng PQ; Zhao LQ; Wang YZ; Miao NJ; Zhou ZL; Cheng Q; Chen PP; Xie HY; Li JY; Ni JY; Zhou L; Zhang W; Wang XX; Liu J; Lu LM
Acta Pharmacol Sin; 2022 Jan; 43(1):86-95. PubMed ID: 33758356
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin Administration Promotes Expression of VEGF in Renal Ischemic–Reperfusion Injury in Rat Model.
Kongkham S; Sriwong S; Tasanarong A
J Med Assoc Thai; 2016 Jul; 99 Suppl 4():S246-55. PubMed ID: 29927177
[TBL] [Abstract][Full Text] [Related]
7. P2X4 receptor exacerbates ischemic AKI and induces renal proximal tubular NLRP3 inflammasome signaling.
Han SJ; Lovaszi M; Kim M; D'Agati V; Haskó G; Lee HT
FASEB J; 2020 Apr; 34(4):5465-5482. PubMed ID: 32086866
[TBL] [Abstract][Full Text] [Related]
8. Renoprotective effect of erythropoietin via modulation of the STAT6/MAPK/NF-κB pathway in ischemia/reperfusion injury after renal transplantation.
Zhang J; Zhao D; Na N; Li H; Miao B; Hong L; Huang Z
Int J Mol Med; 2018 Jan; 41(1):25-32. PubMed ID: 29115389
[TBL] [Abstract][Full Text] [Related]
9. Remote conditioning or erythropoietin before surgery primes kidneys to clear ischemia-reperfusion-damaged cells: a renoprotective mechanism?
Gardner DS; Welham SJ; Dunford LJ; McCulloch TA; Hodi Z; Sleeman P; O'Sullivan S; Devonald MA
Am J Physiol Renal Physiol; 2014 Apr; 306(8):F873-84. PubMed ID: 24523383
[TBL] [Abstract][Full Text] [Related]
10. The administration of erythropoietin attenuates kidney injury induced by ischemia/reperfusion with increased activation of Wnt/β-catenin signaling.
Chen X; Wang CC; Song SM; Wei SY; Li JS; Zhao SL; Li B
J Formos Med Assoc; 2015 May; 114(5):430-7. PubMed ID: 25682558
[TBL] [Abstract][Full Text] [Related]
11. Dopamine D1 receptor agonist A68930 attenuates acute kidney injury by inhibiting NLRP3 inflammasome activation.
Cao JY; Zhou LT; Li ZL; Yang Y; Liu BC; Liu H
J Pharmacol Sci; 2020 Jul; 143(3):226-233. PubMed ID: 32446726
[TBL] [Abstract][Full Text] [Related]
12. NLRP3 inflammasome knockout mice are protected against ischemic but not cisplatin-induced acute kidney injury.
Kim HJ; Lee DW; Ravichandran K; O Keys D; Akcay A; Nguyen Q; He Z; Jani A; Ljubanovic D; Edelstein CL
J Pharmacol Exp Ther; 2013 Sep; 346(3):465-72. PubMed ID: 23833276
[TBL] [Abstract][Full Text] [Related]
13. Methylene blue attenuates renal ischemia-reperfusion injury by negative regulation of NLRP3 signaling pathway.
Liu JJ; Lu L; Hu FQ; Yuan H; Xu Q; Qin YF; Gong JH
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2847-2853. PubMed ID: 29771438
[TBL] [Abstract][Full Text] [Related]
14. Renoprotection and Mechanisms of Erythropoietin and Its Derivatives Helix B Surface Peptide in Kidney Injuries.
Zhang Y; Chen W; Wu Y; Yang B
Curr Protein Pept Sci; 2017; 18(12):1183-1190. PubMed ID: 27634442
[TBL] [Abstract][Full Text] [Related]
15. EZH2 plays a crucial role in ischemia/reperfusion-induced acute kidney injury by regulating p38 signaling.
Liang H; Huang Q; Liao MJ; Xu F; Zhang T; He J; Zhang L; Liu HZ
Inflamm Res; 2019 Apr; 68(4):325-336. PubMed ID: 30820607
[TBL] [Abstract][Full Text] [Related]
16. Role of miR‑21 on vascular endothelial cells in the protective effect of renal delayed ischemic preconditioning.
Xu X; Jiao X; Song N; Luo W; Liang M; Ding X; Teng J
Mol Med Rep; 2017 Sep; 16(3):2627-2635. PubMed ID: 28677811
[TBL] [Abstract][Full Text] [Related]
17. Inflammasome-Independent Role of NLRP3 Mediates Mitochondrial Regulation in Renal Injury.
Kim SM; Kim YG; Kim DJ; Park SH; Jeong KH; Lee YH; Lim SJ; Lee SH; Moon JY
Front Immunol; 2018; 9():2563. PubMed ID: 30483252
[TBL] [Abstract][Full Text] [Related]
18. Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure.
Johnson DW; Pat B; Vesey DA; Guan Z; Endre Z; Gobe GC
Kidney Int; 2006 May; 69(10):1806-13. PubMed ID: 16598197
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin-enhanced endothelial progenitor cell recruitment in peripheral blood and renal vessels during experimental acute kidney injury in rats.
Cakiroglu F; Enders-Comberg SM; Pagel H; Rohwedel J; Lehnert H; Kramer J
Cell Biol Int; 2016 Mar; 40(3):298-307. PubMed ID: 26616141
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo.
Patel NS; Sharples EJ; Cuzzocrea S; Chatterjee PK; Britti D; Yaqoob MM; Thiemermann C
Kidney Int; 2004 Sep; 66(3):983-9. PubMed ID: 15327391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
